Verified Nov 2026
Batteries & E-Mobility
·
South San Francisco, California
·
Since 2013
Cytovale is a medical diagnostics company headquartered in South San Francisco, California, founded in 2013. It employs an estimated 100-200 people and has an estimated annual revenue band of $10-50 million, and it is privately held. The company serves the healthcare sector, with its work centered on rapid detection of sepsis and other immune-mediated conditions. Its IntelliSep test, an FDA-cleared in vitro diagnostic, delivers results in about 8 minutes by assessing the mechanical properties of white blood cells. In March 2026, a multicenter study reported clinical and operational gains after the IntelliSep test was expanded across a health system.
Cytovale at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
2013
Headquarters
South San Francisco, California
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Electronics
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
13 years in operation (founded 2013).
Holds ISO 13485 certification(s) per public sources.
Overview
Cytovale is a medical diagnostics company headquartered in South San Francisco, California, founded in 2013. It employs an estimated 100-200 people and has an estimated annual revenue band of $10-50 million, and it is privately held. The company serves the healthcare sector, with its work centered on rapid detection of sepsis and other immune-mediated conditions. Its IntelliSep test, an FDA-cleared in vitro diagnostic, delivers results in about 8 minutes by assessing the mechanical properties of white blood cells. In March 2026, a multicenter study reported clinical and operational gains after the IntelliSep test was expanded across a health system.
At a glance
Attribute | Detail |
|---|---|
Founded | 2013 |
Headquarters | South San Francisco, California |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Cytovale makes
The company holds ISO 13485 certification and its IntelliSep test is FDA-cleared for sepsis detection, with its platform combining high-resolution imaging, microfluidics, and machine learning.
Certifications
Cytovale is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — arenasolutions.com
Latest developments
2026-09-17 — Another IntelliSep milestone: Baptist Medical Center East in Montgomery is now live. | Cytovale (linkedin.com)
2026-08-25 — Please join us in welcoming Marc Nash, MBA as Chief Operations Officer at Cytovale. | Cytovale (linkedin.com)
2026-04-07 — Cytovale Appoints Eric Khairy as Chief Marketing Officer - Cytovale (cytovale.com)
2026-03-23 — Multicenter Study Shows Reproducible Clinical and Operational Gains Following Expansion of IntelliSep Sepsis Test Across Health System - Cytovale (cytovale.com)
2025-12-03 — Cytovale is expanding in the Northeast! | Valerie Taylor, MBA (linkedin.com)
2025-02-04 — Cytovale Names Dave Vort Chief Commercial Officer (prnewswire.com)
Company details
Cytovale primarily serves Emergency Department clinicians and healthcare facilities seeking quick, objective diagnostic tools, and it is privately held with an estimated 100-200 employees. Cytovale was founded in 2013, has an estimated 100-200 employees, and is headquartered in South San Francisco, California. On the LightSource stability read it is rated "Established & active": 13 years in operation (founded 2013). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Cytovale make?
Cytovale is a medical diagnostics company headquartered in South San Francisco, California, founded in 2013. It employs an estimated 100-200 people and has an estimated annual revenue band of $10-50 million, and it is privately held. The company serves the healthcare sector, with its work centered on rapid detection of sepsis and other immune-mediated conditions. Its IntelliSep test, an FDA-cleared in vitro diagnostic, delivers results in about 8 minutes by assessing the mechanical properties of white blood cells. In March 2026, a multicenter study reported clinical and operational gains after the IntelliSep test was expanded across a health system.
Where is Cytovale headquartered?
Cytovale is headquartered in South San Francisco, California (2 Tower Pl, South San Francisco, California, 94080-1806).
When was Cytovale founded?
Cytovale was founded in 2013.
How big is Cytovale?
Cytovale has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
What certifications does Cytovale hold?
Cytovale lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.